Skip to main content

Table 3 Comparison of antifungal agents used in the treatment of fluconazole resistant and fluconazole-susceptible Candida parapsilosis candidemia

From: Risk factors and outcome for bloodstream infections due to fluconazole-resistant Candida parapsilosis: a 22-year single-center retrospective study

Antifungal

Fluconazole resistant C. parapsilosis (n = 88)

Fluconazole sensitive C. parapsilosis (n = 85)

p value

Fluconazole

54 (61.4%)

62 (72.9%)

0.384

Echinocandin

22 (25.0%)

16 (18.8%)

Liposomal amphotericin B

9 (10.2%)

6 (7.1%)

Voriconazole

3 (3.4%)

1 (1.2%)